Aldosterone changes after parathyroid surgery
Part of Cancer, Heart & circulation, Hormones & metabolism clinical trials.
This study looks at how a hormone called aldosterone, which helps control blood pressure, changes after surgery for primary hyperparathyroidism. It may help doctors understand the link between this condition and blood pressure issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with primary hyperparathyroidism and are scheduled for surgery.
- You do not have kidney disease (with a specific kidney function level below 60).
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with primary hyperparathyroidism (a hormone-related condition that affects calcium levels). It aims to better understand the condition and who it affects, which may help improve care over time.
This is an observational study that follows people who have or may develop parathyroid-related conditions. The goal is to better understand how these problems change over time and what patterns show up, which can help improve future care.
This study tests whether giving a bisphosphonate (a bone-strengthening drug) before parathyroid surgery helps protect bone health in people with primary hyperparathyroidism. It's for those who already have thin bones and are planning surgery.
This study looks at the genetic makeup of parathyroid tumors in people with hyperparathyroidism. It aims to understand why these tumors form and how they behave, which could help improve treatment decisions.
This study looks at whether a simple blood test result taken right after adrenal gland removal surgery can predict how blood pressure will improve later. If you've had this surgery, joining could help doctors understand better outcomes for future patients.
This trial compares two surgical approaches for severe secondary hyperparathyroidism caused by kidney disease: removing all parathyroid tissue alone versus removing it and moving some tissue back into the body. The study aims to see which approach works better and is safer for controlling the hormone problem.
Hear when a new Primary Hyperparathyroidism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.